HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure LC Swenson, JE Min, CK Woods, E Cai, JZ Li, JSG Montaner, ... Aids 28 (8), 1125-1134, 2014 | 113 | 2014 |
Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals A Gonzalez-Serna, JE Min, C Woods, D Chan, VD Lima, JSG Montaner, ... Clinical infectious diseases 58 (8), 1165-1173, 2014 | 100 | 2014 |
Different biological significance of sCD14 and LPS in HIV-infection: importance of the immunovirology stage and association with HIV-disease progression markers MC Romero-Sánchez, A González-Serna, YM Pacheco, ... Journal of Infection 65 (5), 431-438, 2012 | 66 | 2012 |
Rapid decrease in peripheral blood mononucleated cell telomere length after HIV seroconversion, but not HCV seroconversion A Gonzalez-Serna, A Ajaykumar, I Gadawski, MA Muñoz-Fernández, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 76 (1), e29-e32, 2017 | 37 | 2017 |
Correlation between the Trofile® test and virological response to a short-term maraviroc exposure in HIV-infected patients M Genebat, E Ruiz-Mateos, JA Leon, A Gonzalez-Serna, I Pulido, I Rivas, ... Journal of antimicrobial chemotherapy 64 (4), 845-849, 2009 | 34 | 2009 |
COVID‐19 in hospitalized HIV‐positive and HIV‐negative patients: A matched study C Díez, J Del Romero‐Raposo, R Mican, JC López, JR Blanco, ... HIV medicine 22 (9), 867-876, 2021 | 32 | 2021 |
A single untimed plasma drug concentration measurement during low-level HIV viremia predicts virologic failure A Gonzalez-Serna, LC Swenson, B Watson, W Zhang, A Nohpal, ... Clinical Microbiology and Infection 22 (12), 1004. e9-1004. e16, 2016 | 30 | 2016 |
Temporal trends in the discontinuation of first-line antiretroviral therapy A Gonzalez-Serna, K Chan, B Yip, W Chau, R McGovern, H Samji, ... Journal of Antimicrobial Chemotherapy 69 (8), 2202-2209, 2014 | 30 | 2014 |
TROCAI (tropism coreceptor assay information): a new phenotypic tropism test and its correlation with Trofile enhanced sensitivity and genotypic approaches A Gonzalez-Serna, M Leal, M Genebat, MA Abad, A Garcia-Perganeda, ... Journal of clinical microbiology 48 (12), 4453-4458, 2010 | 30 | 2010 |
Correlation of the virological response to short-term maraviroc monotherapy with standard and deep-sequencing-based genotypic tropism prediction methods A Gonzalez-Serna, RA McGovern, PR Harrigan, F Vidal, AFY Poon, ... Antimicrobial agents and chemotherapy 56 (3), 1202-1207, 2012 | 28 | 2012 |
Effect of maraviroc on HIV disease progression-related biomarkers MC Romero-Sánchez, K Machmach, A Gonzalez-Serna, M Genebat, ... Antimicrobial agents and chemotherapy 56 (11), 5858-5864, 2012 | 25 | 2012 |
High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment J Macias, A Pinilla, FA Lao-Dominguez, A Corma, E Contreras-Macias, ... Scientific Reports 10 (1), 20958, 2020 | 21 | 2020 |
Long-term immunovirogical effect and tolerability of a maraviroc-containing regimen in routine clinical practice M Genebat, E Ruiz-Mateos, I Pulido, A Gonzalez-Serna, ... Current HIV Research 8 (6), 482-486, 2010 | 21 | 2010 |
Maintenance of virologic efficacy and decrease in levels of β2-microglobulin, soluble CD40L and soluble CD14 after switching previously treated HIV-infected patients to an NRTI … MC Romero-Sánchez, AI Álvarez-Ríos, E Bernal-Morell, M Genebat, ... Antiviral research 111, 26-32, 2014 | 16 | 2014 |
Incidence of recently acquired hepatitis C virus infection among HIV‐infected patients in southern Spain A Gonzalez‐Serna, J Macias, R Palacios, C Gómez‐Ayerbe, F Tellez, ... HIV medicine 22 (5), 379-386, 2021 | 14 | 2021 |
Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors E Ruiz-Mateos, A González-Serna, M Genebat, K Machmach, F Vidal, ... Antimicrobial agents and chemotherapy 55 (10), 4664-4669, 2011 | 13 | 2011 |
Discordance rates between Trofile® test and short-term virological response to maraviroc M Genebat, E Ruiz-Mateos, A González-Serna, I Pulido, ... Antiviral research 89 (2), 182-185, 2011 | 13 | 2011 |
Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy PD Juan Macías, MD, MD Paz González-Moreno, ... medRxiv 20104141 (https://doi.org/10.1101/2020.05.16.2010), 20104141, 2020 | 11* | 2020 |
Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events J Martínez-Sanz, J Díaz-Álvarez, M Rosas, R Ron, JA Iribarren, E Bernal, ... EBioMedicine 95, 2023 | 9 | 2023 |
Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study B Alejos, I Suárez-García, M Rava, A Bautista-Hernández, F Gutierrez, ... Journal of Antimicrobial Chemotherapy 75 (10), 3004-3014, 2020 | 9 | 2020 |